spect Search Results


msg1000  (Golden West Biologicals)
90
Golden West Biologicals msg1000
Msg1000, supplied by Golden West Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spect/Mass+Spect+Gold+Human+Serum%2C+Ultra-Low+Vitamin+D%2C+Lipid+Free/us12630505-748-31-32
Average 90 stars, based on 1 article reviews
msg1000 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
milabs vector6 spect ct system  (MILabs)
97
MILabs milabs vector6 spect ct system
Milabs Vector6 Spect Ct System, supplied by MILabs, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spect/Single+photon+Emission+Computed+Tomography/10__1016_slash_j__eanmi__2026__100145-76-9-9
Average 97 stars, based on 1 article reviews
milabs vector6 spect ct system - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier
spect ct  (New Brunswick Scientific)
86
New Brunswick Scientific spect ct
Spect Ct, supplied by New Brunswick Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spect/ct+spect/10__51731_slash_cjht__2024__952-54-125-95
Average 86 stars, based on 1 article reviews
spect ct - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
micro ct machine  (MILabs)
97
MILabs micro ct machine
Micro Ct Machine, supplied by MILabs, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spect/Computed+Tomography/10__1016_slash_j__celbio__2026__100534-221-11-14
Average 97 stars, based on 1 article reviews
micro ct machine - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier
vivo imaging system  (MILabs)
96
MILabs vivo imaging system
Vivo Imaging System, supplied by MILabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spect/Optical+Imaging/pmc09318050-105-24-33
Average 96 stars, based on 1 article reviews
vivo imaging system - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
gel imaging system  (VILBER GmbH)
99
VILBER GmbH gel imaging system
Gel Imaging System, supplied by VILBER GmbH, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spect/FUSION+SPECTRA/10__31083_slash_jin51769-174-8-14
Average 99 stars, based on 1 article reviews
gel imaging system - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
simultaneous pet spect imaging  (MILabs)
94
MILabs simultaneous pet spect imaging
<t>(A)</t> <t>PET/SPECT</t> images of mice bearing MDA-MB-468 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (C) Tumour-to-blood ratios and (D) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance).
Simultaneous Pet Spect Imaging, supplied by MILabs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spect/PET%2FSPECT/pmc06599172-5-0-5
Average 94 stars, based on 1 article reviews
simultaneous pet spect imaging - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
mineral oil  (Thermo Fisher)
91
Thermo Fisher mineral oil
<t>(A)</t> <t>PET/SPECT</t> images of mice bearing MDA-MB-468 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (C) Tumour-to-blood ratios and (D) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance).
Mineral Oil, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spect/Mineral+oil%2C+for+spectroscopy%2C+suitable+for+nujol+mull+preparations+for+IR-spect/pm37750327-61-10-12
Average 91 stars, based on 1 article reviews
mineral oil - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier
pmb1 spect pthrc3 8 egfp plasmid  (Addgene inc)
92
Addgene inc pmb1 spect pthrc3 8 egfp plasmid
<t>(A)</t> <t>PET/SPECT</t> images of mice bearing MDA-MB-468 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (C) Tumour-to-blood ratios and (D) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance).
Pmb1 Spect Pthrc3 8 Egfp Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spect/pMB1-spect-PthrC3_8-eGFP+(Plasmid+%23107411)/10__3390_slash_agriculture14101684-56-1-27
Average 92 stars, based on 1 article reviews
pmb1 spect pthrc3 8 egfp plasmid - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier
one set  (Golden West Biologicals)
93
Golden West Biologicals one set
<t>(A)</t> <t>PET/SPECT</t> images of mice bearing MDA-MB-468 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (C) Tumour-to-blood ratios and (D) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance).
One Set, supplied by Golden West Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spect/Mass+Spect+Gold+Human+Serum%2C+Ultra-Low+Hormones+%26+Steroids/pm36388059-61-0-10
Average 93 stars, based on 1 article reviews
one set - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
human control serum  (Golden West Biologicals)
92
Golden West Biologicals human control serum
<t>(A)</t> <t>PET/SPECT</t> images of mice bearing MDA-MB-468 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (C) Tumour-to-blood ratios and (D) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance).
Human Control Serum, supplied by Golden West Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spect/Mass+Spect+Gold+Human+Serum%2C+Ultra-Low+Hormones+%26+Steroids%2C+Lipid+Free/pm38020477-78-0-9
Average 92 stars, based on 1 article reviews
human control serum - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier
mass spect gold serum  (Golden West Biologicals)
93
Golden West Biologicals mass spect gold serum
<t>(A)</t> <t>PET/SPECT</t> images of mice bearing MDA-MB-468 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (C) Tumour-to-blood ratios and (D) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance).
Mass Spect Gold Serum, supplied by Golden West Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spect/Mass+Spect+Gold+Human+Serum%2C+Catecholamine+Free/10__47429_slash_lmo__2025__15__2__214-72-36-40
Average 93 stars, based on 1 article reviews
mass spect gold serum - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

Image Search Results


(A) PET/SPECT images of mice bearing MDA-MB-468 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (C) Tumour-to-blood ratios and (D) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance).

Journal: Nuclear Medicine and Biology

Article Title: Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours ☆ ☆☆

doi: 10.1016/j.nucmedbio.2019.01.010

Figure Lengend Snippet: (A) PET/SPECT images of mice bearing MDA-MB-468 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (C) Tumour-to-blood ratios and (D) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance).

Article Snippet: Simultaneous PET/SPECT imaging using a MILabs Vector4 small animal scanner revealed stark differences in the intratumoural distribution of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG, highlighting regions of HER2-mediated uptake and non-specific uptake, respectively.

Techniques: Single Photon Emission Computed Tomography, Injection

(A) PET/SPECT images of mice bearing MDA-MB-231 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) PET/SPECT images of mice bearing MDA-MB-231 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab, [ 111 In]In-IgG, and a blocking dose (0.5 mg) of unlabelled trastuzumab. (C) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (D) Tumour-to-blood ratios and (E) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance; *P < 0.05).

Journal: Nuclear Medicine and Biology

Article Title: Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours ☆ ☆☆

doi: 10.1016/j.nucmedbio.2019.01.010

Figure Lengend Snippet: (A) PET/SPECT images of mice bearing MDA-MB-231 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) PET/SPECT images of mice bearing MDA-MB-231 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab, [ 111 In]In-IgG, and a blocking dose (0.5 mg) of unlabelled trastuzumab. (C) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (D) Tumour-to-blood ratios and (E) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance; *P < 0.05).

Article Snippet: Simultaneous PET/SPECT imaging using a MILabs Vector4 small animal scanner revealed stark differences in the intratumoural distribution of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG, highlighting regions of HER2-mediated uptake and non-specific uptake, respectively.

Techniques: Single Photon Emission Computed Tomography, Injection, Blocking Assay

(A) PET/SPECT images of mice bearing MDA-MB-231/H2N tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) PET/SPECT images of mice bearing MDA-MB-231/H2N tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab, [ 111 In]In-IgG, and a blocking dose (0.5 mg) of unlabelled trastuzumab. (C) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (D) Tumour-to-blood ratios and (E) tumour-to-muscle ratios for each radiolabelled agent. (*P < 0.05; ****P < 0.0001).

Journal: Nuclear Medicine and Biology

Article Title: Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours ☆ ☆☆

doi: 10.1016/j.nucmedbio.2019.01.010

Figure Lengend Snippet: (A) PET/SPECT images of mice bearing MDA-MB-231/H2N tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) PET/SPECT images of mice bearing MDA-MB-231/H2N tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab, [ 111 In]In-IgG, and a blocking dose (0.5 mg) of unlabelled trastuzumab. (C) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (D) Tumour-to-blood ratios and (E) tumour-to-muscle ratios for each radiolabelled agent. (*P < 0.05; ****P < 0.0001).

Article Snippet: Simultaneous PET/SPECT imaging using a MILabs Vector4 small animal scanner revealed stark differences in the intratumoural distribution of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG, highlighting regions of HER2-mediated uptake and non-specific uptake, respectively.

Techniques: Single Photon Emission Computed Tomography, Injection, Blocking Assay

(A) PET/SPECT images of mice bearing SKBR3 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) PET/SPECT images of mice bearing SKBR3 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab, [ 111 In]In-IgG, and a blocking dose (0.5 mg) of unlabelled trastuzumab. (C) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (D) Tumour-to-blood ratios and (E) tumour-to-muscle ratios for each radiolabelled agent. (***P < 0.001; ****P < 0.0001).

Journal: Nuclear Medicine and Biology

Article Title: Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours ☆ ☆☆

doi: 10.1016/j.nucmedbio.2019.01.010

Figure Lengend Snippet: (A) PET/SPECT images of mice bearing SKBR3 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) PET/SPECT images of mice bearing SKBR3 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab, [ 111 In]In-IgG, and a blocking dose (0.5 mg) of unlabelled trastuzumab. (C) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (D) Tumour-to-blood ratios and (E) tumour-to-muscle ratios for each radiolabelled agent. (***P < 0.001; ****P < 0.0001).

Article Snippet: Simultaneous PET/SPECT imaging using a MILabs Vector4 small animal scanner revealed stark differences in the intratumoural distribution of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG, highlighting regions of HER2-mediated uptake and non-specific uptake, respectively.

Techniques: Single Photon Emission Computed Tomography, Injection, Blocking Assay